The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials.

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad.

Afiliação

Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia. Electronic address: chiasiang_93@hotmail.com.
Ramachandram DS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia.
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

J Infect Chemother ; 28(2): 257-265, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34840039

Assuntos

COVID-19; Anticoagulantes/efeitos adversos; Hemorragia/induzido quimicamente; Hemorragia/epidemiologia; Humanos; Ensaios Clínicos Controlados Aleatórios como Assunto; SARS-CoV-2

Palavras-chave

Anticoagulant; COVID-19; Enoxaparin; Heparin; Mortality; Thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google